1,037
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Increased incidence of gonorrhoea and chlamydia in Greenland 1990–2012

, , , , &
Article: 1324748 | Received 21 Dec 2016, Accepted 18 Apr 2017, Published online: 01 Jun 2017
 

ABSTRACT

Background: Since the 1970s, Greenland has presented the highest reported incidence rates of the sexually transmitted infections (STIs) gonorrhoea and chlamydia in the Arctic regions.

Objective: This study aims to describe sex- and age-specific incidence rates of gonorrhoea and chlamydia from 1990 to 2012 in Greenland, and to evaluate if changes in case definitions, diagnostic procedures and implementation of STI interventions during the period coincide with rate changes.

Design: Gonorrhoea and chlamydia cases were identified from the national STI surveillance. For 1990–2008, STI cases were identified from weekly notified aggregated data. For 2009–2012, cases were identified in person-identifiable national registers. We used log-linear Poisson regression to calculate incidence rates (IRs) and incidence rate ratios (IRRs) with 95% confidence intervals (95% CI). Analyses were stratified according to sex, age and calendar period.

Results: Gonorrhoea and chlamydia incidence rates have increased since 1995 to reach 2,555 per 100,000 person-years (PY) for gonorrhoea and 6,403 per 100,000 PY for chlamydia in 2012. From 2006 to 2012, the incidence rates among young adults aged 15–19 years were 8,187 and 22,515 per 100,000 PY for gonorrhoea and chlamydia, respectively. Changes in surveillance reporting did not seem to influence the incidence rates for either disease, whereas a change in diagnostic test coincided with an increased incidence of chlamydia.

Conclusion: Overall, the incidence of chlamydia in Greenland increased during the study period, whereas the incidence of gonorrhoea decreased until 1995 but increased thereafter. Young adults aged 15–24 years were at highest risk of infection. The increase in incidence rates was independent of changes in case definitions, whereas an observed increase in chlamydia incidence in 2005 coincided with a change in diagnostic test. None of the STI interventions launched after 1995 seemed to coincide with decreasing national incidence rates.

Acknowledgments

We wish to thank the National Board of Health (Nuuk, Greenland) for supplying STI notification data, and senior medical laboratory technologist I-L Kleist and laboratory technician P Poulsen (Central laboratory, Nuuk, Greenland) for information on diagnostic procedures in Greenland. We also wish to thank senior regional doctor O Rosing Olsen for information about STI surveillance and diagnostic procedures in Sisimiut and Maniitsoq. We would like to thank M Andersson for generating data from Greenlandic national registries. Furthermore, we wish to thank former head of the prevention board PAARISA, B Karlshøj, for information about STI interventions launched in Greenland.

Aase og Ejnar Danielsens Fond, Beckett-fonden, Direktør Jacob Madsen & Hustru Olga Madsens Fond and Sundhedspuljen Greenlandic Self-Government funded the study.

Conflict of Interest

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Beckett-fonden; Sundhedspuljen, Greenlandic Self-Government; Direktør Jacob Madsen og Hustru Olga Madsens Fond (DK); Aase og Ejnar Danielsens Fond (DK).